Dolores Isla
Servicio Aragonés de Salud(ES)Hospital Clínico Universitario Lozano Blesa(ES)Instituto de Investigación Sanitaria Aragón(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial(2012)5,500 cited
- → Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer(2009)2,363 cited
- → A variant associated with nicotine dependence, lung cancer and peripheral arterial disease(2008)1,519 cited
- → Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial(2022)710 cited
- → Sequence variants at the TERT-CLPTM1L locus associate with many cancer types(2009)611 cited
- → Phase III Study Comparing Cisplatin Plus Fluorouracil to Paclitaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer